Author:
Ziegler Andreas,Walter Maggie C.,Schoser Benedikt E.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Neurology (clinical),Neurology,General Medicine
Reference57 articles.
1. Aartsma-Rus A, Fokkema I, Verschuuren J et al (2009) Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations. Hum Mutat 30:293–299
2. Al-Zaidy SA, Sahenk Z, Rodino-Klapac LR et al (2015) Follistatin gene therapy improves ambulation in Becker muscular dystrophy. J Neuromuscul Dis 2:185–192
3. Angelini C (1993) Calpainopathy. In: Adam MP, Everman DB, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A (Hrsg) GeneReviews(®). University of Washington, Seattle
4. Angelini C (2020) LGMD. Identification, description and classification. Acta Myol 39:207–217
5. Bushby K, Finkel R, Birnkrant DJ et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93